2026-2030年全球傷口清創市場

全球傷口清創市場預計將從 2025 年到 2030 年成長至 5.516 億美元，預測期內複合年成長率為 7.1%。

本報告對全球傷口清創市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及供應商分析，涵蓋約 25 家供應商。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：全球慢性病盛行率上升和人口老化、清創產品技術的不斷進步以及外科手術和創傷病例數量的增加。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場資訊（包括區域分析）以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，先進的微創傷口清創技術的日益普及是未來幾年全球傷口清創市場成長的主要促進因素之一。此外，人們對聯合治療和多功能產品的興趣日益濃厚，以及創傷護理服務模式向居家醫療和門診模式的轉變，預計也將產生顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球傷口清創市場
• 2020年至2024年最終用戶細分市場分析
• 產品細分市場分析，2020-2024 年
• 產品類型細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球傷口清創市場
• 地緣政治衝突的影響：全球傷口清創市場

第7章：五力分析

第8章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院
• 診所
• 其他
• 市場機會：依最終用戶分類

第9章 市場區隔：依產品

• 比較：按產品
• 專制主義者
• 外科
• 機械的
• 酵素
• 其他
• 市場機會：依產品分類

第10章 市場區隔：依產品類型

• 比較：依產品類型
• 凝膠
• 藥膏和乳霜
• 傷口沖洗液
• 市場機會：依產品類型分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 土耳其
  • 沙烏地阿拉伯
  • UAE
  • 阿根廷
  • 南非
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• 3M Co.
• B.Braun SE
• Bioventus LLC
• Cardinal Health Inc.
• Coloplast AS
• ConvaTec Group Plc
• DeRoyal Industries Inc.
• Integra LifeSciences Corp.
• Medline Inc.
• Molnlycke Health Care AB
• Organogenesis Holdings Inc.
• Paul Hartmann AG
• Smith and Nephew plc
• Stryker Corp.
• Zimmer Biomet Holdings Inc.

第16章附錄

The global wound debridement market is forecasted to grow by USD 551.6 mn during 2025-2030, accelerating at a CAGR of 7.1% during the forecast period. The report on the global wound debridement market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of chronic diseases and aging population, continuous technological advancements in debridement products, increasing volume of surgical procedures and trauma incidences.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global wound debridement market is segmented as below:

By End-User

• Hospitals
• Clinics
• Others

By Product

• Autolytic
• Surgical
• Mechanical
• Enzymatic
• Others

By Product Type

• Gels
• Ointments and creams
• Wound irrigation solution

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the growing adoption of advanced and minimally invasive debridement technologies as one of the prime reasons driving the global wound debridement market growth during the next few years. Also, increasing focus on combination therapies and multifunctional products and shift of wound care delivery toward home healthcare and outpatient settings will lead to sizable demand in the market.

The report on the global wound debridement market covers the following areas:

• Global wound debridement market sizing
• Global wound debridement market forecast
• Global wound debridement market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global wound debridement market vendors that include 3M Co., Arobella Medical LLC, B.Braun SE, BioMonde Ltd., Bioventus LLC, Cardinal Health Inc., Coloplast AS, ConvaTec Group Plc, Covalon Technologies Ltd., DeRoyal Industries Inc., Integra LifeSciences Corp., Mediwound Ltd., Medline Inc., Molnlycke Health Care AB, Monarch Labs Inc., Organogenesis Holdings Inc., Paul Hartmann AG, Smith and Nephew plc, Stryker Corp., Zimmer Biomet Holdings Inc.. Also, the global wound debridement market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Wound Debridement Market 2020 - 2024
  • Historic Market Size - Data Table on Global Wound Debridement Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Wound Debridement Market
• 6.2 Impact of Geopolitical Conflicts on Global Wound Debridement Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Hospitals - Market size and forecast 2025-2030
• 8.4 Clinics - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 Autolytic - Market size and forecast 2025-2030
• 9.4 Surgical - Market size and forecast 2025-2030
• 9.5 Mechanical - Market size and forecast 2025-2030
• 9.6 Enzymatic - Market size and forecast 2025-2030
• 9.7 Others - Market size and forecast 2025-2030
• 9.8 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 Gels - Market size and forecast 2025-2030
• 10.4 Ointments and creams - Market size and forecast 2025-2030
• 10.5 Wound irrigation solution - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Turkey - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global prevalence of chronic diseases and aging population
  • Continuous technological advancements in debridement products
  • Increasing volume of surgical procedures and trauma incidences
• 13.2 Market challenges
  • High cost of advanced treatments and reimbursement constraints
  • Shortage of skilled healthcare professionals
  • Stringent and complex regulatory environment
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Growing adoption of advanced and minimally invasive debridement technologies
  • Increasing focus on combination therapies and multifunctional products
  • Shift of wound care delivery toward home healthcare and outpatient settings

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 3M Co.
  • 3M Co. - Overview
  • 3M Co. - Business segments
  • 3M Co. - Key news
  • 3M Co. - Key offerings
  • 3M Co. - Segment focus
  • SWOT
• 15.5 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key offerings
  • SWOT
• 15.6 Bioventus LLC
  • Bioventus LLC - Overview
  • Bioventus LLC - Business segments
  • Bioventus LLC - Key offerings
  • Bioventus LLC - Segment focus
  • SWOT
• 15.7 Cardinal Health Inc.
  • Cardinal Health Inc. - Overview
  • Cardinal Health Inc. - Business segments
  • Cardinal Health Inc. - Key news
  • Cardinal Health Inc. - Key offerings
  • Cardinal Health Inc. - Segment focus
  • SWOT
• 15.8 Coloplast AS
  • Coloplast AS - Overview
  • Coloplast AS - Business segments
  • Coloplast AS - Key offerings
  • Coloplast AS - Segment focus
  • SWOT
• 15.9 ConvaTec Group Plc
  • ConvaTec Group Plc - Overview
  • ConvaTec Group Plc - Product / Service
  • ConvaTec Group Plc - Key offerings
  • SWOT
• 15.10 DeRoyal Industries Inc.
  • DeRoyal Industries Inc. - Overview
  • DeRoyal Industries Inc. - Product / Service
  • DeRoyal Industries Inc. - Key offerings
  • SWOT
• 15.11 Integra LifeSciences Corp.
  • Integra LifeSciences Corp. - Overview
  • Integra LifeSciences Corp. - Business segments
  • Integra LifeSciences Corp. - Key offerings
  • Integra LifeSciences Corp. - Segment focus
  • SWOT
• 15.12 Medline Inc.
  • Medline Inc. - Overview
  • Medline Inc. - Product / Service
  • Medline Inc. - Key news
  • Medline Inc. - Key offerings
  • SWOT
• 15.13 Molnlycke Health Care AB
  • Molnlycke Health Care AB - Overview
  • Molnlycke Health Care AB - Product / Service
  • Molnlycke Health Care AB - Key offerings
  • SWOT
• 15.14 Organogenesis Holdings Inc.
  • Organogenesis Holdings Inc. - Overview
  • Organogenesis Holdings Inc. - Business segments
  • Organogenesis Holdings Inc. - Key offerings
  • Organogenesis Holdings Inc. - Segment focus
  • SWOT
• 15.15 Paul Hartmann AG
  • Paul Hartmann AG - Overview
  • Paul Hartmann AG - Business segments
  • Paul Hartmann AG - Key offerings
  • Paul Hartmann AG - Segment focus
  • SWOT
• 15.16 Smith and Nephew plc
  • Smith and Nephew plc - Overview
  • Smith and Nephew plc - Business segments
  • Smith and Nephew plc - Key offerings
  • Smith and Nephew plc - Segment focus
  • SWOT
• 15.17 Stryker Corp.
  • Stryker Corp. - Overview
  • Stryker Corp. - Business segments
  • Stryker Corp. - Key offerings
  • Stryker Corp. - Segment focus
  • SWOT
• 15.18 Zimmer Biomet Holdings Inc.
  • Zimmer Biomet Holdings Inc. - Overview
  • Zimmer Biomet Holdings Inc. - Business segments
  • Zimmer Biomet Holdings Inc. - Key news
  • Zimmer Biomet Holdings Inc. - Key offerings
  • Zimmer Biomet Holdings Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations